<img src="https://pubads.g.doubleclick.net/activity;dc_iu=/5206/invc.invc/VisibleAlpha_Blog_RT;ord=1?" width="1" height="1" border="0/">

The Edge | Johnathan Ritucci

Company Analysis Company Analysis - Consumer Discretionary
Jun 30. 2020

Analysts See Long Route To Recovery For European Airport Operators

The novel coronavirus pandemic was timed poorly for major European airport operators (Aena, Fraport and Aéroports de Paris) that were already ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Consumer Discretionary
Jun 19. 2020

Hotel Stocks Now Valued Higher Than Before COVID-19

The hotel industry is facing headwinds caused by the COVID-19 pandemic, which brought leisure and business travel to a virtual standstill in the ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Consumer Discretionary
Jun 12. 2020

Analysts Still Forecast Slow Recovery For Cruise Liners

The cruise industry was severely hurt by the novel coronavirus pandemic after multiple ships were quarantined at sea for ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Health Care
Jun 08. 2020

Moderna’s COVID-19 Vaccine Estimates Highlight Analyst Disharmony

Moderna’s novel coronavirus vaccine (mRNA-1273) is a front-running candidate to be one of the first available to market. If successful, the ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Industrials
May 19. 2020

Major U.S. Airlines Are Not Expected To Recover From COVID Until 2022 At The Earliest

Wall Street analysts believe the four largest U.S. airlines – Delta (DAL), United (UAL), American (AAL) and Southwest (LUV) – will lose 50-60% ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Technology
May 13. 2020

Snapchat, Facebook Expected To Weather Covid-19 Storm Better Than Peers

The Covid-19 pandemic is shifting a larger portion of consumer budgets online and shaking up the digital advertising industry. Analysts believe ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Health Care
May 06. 2020

Gilead Analysts Begin Forecasting Remdesivir Sales for Covid-19 Treatment

The U.S. Food and Drug Administration (FDA) recently approved Gilead’s antiviral Remdesivir for emergency use authorization (EUA) as a treatment ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Consumer Discretionary
Apr 30. 2020

Netflix Analysts Pull Forward Subscriber Growth Forecast After Signup Surge

On April 21, Netflix reported exceedingly better-than-expected net new subscribers in their fiscal 1Q20 as COVID-19 induced lockdowns confined ...

author: Johnathan Ritucci

Company Analysis
Apr 17. 2020

COVID-19 Analyst Revisions Ahead of Earnings Season

Earnings season is here, and companies are expected to update full-year guidance to reflect the impact of the COVID-19 crisis. As events have ...

author: Johnathan Ritucci

Company Analysis Company Analysis - Consumer Discretionary
Apr 02. 2020

Nike Expected To Recover Faster Than Adidas in China

For both Nike and Adidas, the Greater China market is a strategically important growth driver, but after both companies provided updates on how ...

author: Johnathan Ritucci